Navidea biopharmaceuticals to host third quarter 2022 earnings conference call and business update

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call and webcast on tuesday, november 15, 2022 at 5:00 p.m.
NAVB Ratings Summary
NAVB Quant Ranking